Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study
| dc.contributor.author | Chappell, Francesca M. | |
| dc.contributor.author | Valdes Hernandez, Maria del Carmen | |
| dc.contributor.author | Makin, Stephen D. | |
| dc.contributor.author | Shuler, Kirsten | |
| dc.contributor.author | Sakka, Eleni | |
| dc.contributor.author | Dennis, Martin S. | |
| dc.contributor.author | Armitage, Paul A. | |
| dc.contributor.author | Munoz Maniega, Susana | |
| dc.contributor.author | Wardlaw, Joanna M. | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2020-06-05T13:25:01Z | |
| dc.date.available | 2020-06-05T13:25:01Z | |
| dc.date.issued | 2017-02-21 | |
| dc.description | We thank the staff of the Brain Research Imaging Centre (http://www.sbirc.ed.ac.uk/) and Neuroimaging Sciences (http://www.ed.ac.uk/clinical-brain-sciences/research/research-methodologies/neuroimaging), University of Edinburgh, but mostly all the participants and relatives who took part in the study. This work was funded by the Wellcome Trust (grant 088134/Z/09/A), Row Fogo Charitable Trust, Age UK, Scottish Funding Council and the Chief Scientist Office of Scotland for the Scottish Imaging Network: A Platform for Scientific Excellence (“SINAPSE”) and the Brain Research Imaging Centre. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 494053 | |
| dc.identifier | 147310966 | |
| dc.identifier | 27392afd-e568-4b21-962c-f1389c152ab2 | |
| dc.identifier | 85014350854 | |
| dc.identifier.citation | Chappell, F M, Valdes Hernandez, M D C, Makin, S D, Shuler, K, Sakka, E, Dennis, M S, Armitage, P A, Munoz Maniega, S & Wardlaw, J M 2017, 'Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study', Trials, vol. 18, 78. https://doi.org/10.1186/s13063-017-1825-7 | en |
| dc.identifier.doi | 10.1186/s13063-017-1825-7 | |
| dc.identifier.issn | 1745-6215 | |
| dc.identifier.other | RIS: urn:92DBF99EAA9664CCE487C080D7A8C27F | |
| dc.identifier.other | RIS: 10873 | |
| dc.identifier.other | ORCID: /0000-0001-8701-9043/work/76976283 | |
| dc.identifier.uri | https://hdl.handle.net/2164/14452 | |
| dc.identifier.url | https://pubmed.ncbi.nlm.nih.gov/28222778/ | en |
| dc.identifier.vol | 18 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Trials | en |
| dc.subject | White matter hyperintensities | en |
| dc.subject | Sample size calculation | en |
| dc.subject | Study design | en |
| dc.subject | R Medicine | en |
| dc.subject | Wellcome Trust | en |
| dc.subject | 088134/Z/09/A | en |
| dc.subject | Scottish Funding Council | en |
| dc.subject | Scottish Imaging Network | en |
| dc.subject | SINAPSE | en |
| dc.subject.lcc | R | en |
| dc.title | Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Chappel_et_al_BMCTrials_Sample_size_considerations_VOR.pdf
- Size:
- 482.47 KB
- Format:
- Adobe Portable Document Format
